首页|低分子肝素钙联合椎体成形术治疗老年骨折疏松性椎体压缩性骨折的临床疗效

低分子肝素钙联合椎体成形术治疗老年骨折疏松性椎体压缩性骨折的临床疗效

扫码查看
目的 探讨低分子肝素钙联合椎体成形术治疗老年骨折疏松性椎体压缩性骨折的临床疗效及价值.方法 选择天津市第三中心医院分院2013年1月~2016年1月老年骨质疏松性椎体压缩性骨折患者67例,随机分为对照组30例和治疗组37例.所有患者均行经皮椎体成形术,对照组术后予以碳酸钙D3片常规治疗,治疗组予以低分子肝素钙抗骨质疏松治疗,疗程均为1个月.检测术前及术后不同随访时间点骨密度(BMD)变化情况及采用Oswestry功能障碍指数(ODI)评估活动能力及疼痛视觉模拟评分(VAS)评估疼痛程度,并分析手术前后椎体高度变化情况.结果 所有患者术后均进行随访,随访时间为12~21个月,平均16.4月.相比椎体成形术前,治疗组患者术后1月、3月、6月较对照组BMD一定程度增高,差异有统计学意义(P<0.05);经低分子肝素钙治疗1月后,治疗组VAS评分及ODI评分均显著低于对照组,且后续不同随访时间点ODI评分及VAS评分均能有效维持,差异有统计学意义(P<0.05).相比椎体成形术前,患者术后椎体前缘高度、中部高度优于术前椎体高度,差异有统计学意义(P<0.05);且治疗1月后,治疗组椎体前缘高度、中部高度均优于对照组,差异有统计学意义(P<0.05).结论 经低分子肝素钙治疗后,伴随椎体成形术后椎体愈合进程,一定程度上增加了老年骨折疏松性椎体压缩性骨折患者的骨量以及防止骨破坏,增加骨强度,进一步达到治疗骨质疏松及预防骨质疏松性术后再次骨折.
Clinical effect of low molecular weight heparin calcium combined with vertebroplasty in osteoporotic vertebral compression fractures in elderly patients
Objective To investigate the clinical efficacy and value of low molecular weight heparin calcium combined with vertebroplasty in the treatment of osteoporotic vertebral compression fractures in elderly patients .Methods 67 elderly patients with osteoporotic vertebral compression fractures in our hospital from January 2013 to January 2016 were selected and randomly divided into control group 30 cases and treatment group 37 cases. All patients were treated with percutaneous vertebroplasty, the control group was given calcium carbonate D3 conventional treatment, the treatment group was treated with low molecular weight heparin calcium anti osteoporosis treatment, the course of treatment was one month.Measurement of bone mineral density before and after the operation of different follow-up time points ( BMD ) and the changes of the oswestry disability index ( ODI ) evaluation activities and the visual analogue scale (VAS) to assess the degree of pain, and the changes of vertebral height before and after operation were analyzed. Results All patients were followed up for an average of 16.4 months (12 to 21 months).Compared with before vertebroplasty, the BMD of the patients in the treatment group was higher than that in the control group at one month, three months and six months, the difference was statistically significant (P<0.05), the low molecular weight heparin treatment after January, treatment group VAS and ODI scores were significantly lower than the control group, and the subsequent different follow-up time points ODI and VAS score can effectively maintain, the difference was statistically significant ( P<0.05) .Compared with before vertebroplasty, postoperative anterior vertebral height, middle height better than preoperative vertebral height, the difference was statistically significant (P<0.05), and after one months of treatment, the treatment group of anterior vertebral height, middle height were better than the control group, the difference was statistically significant (P <0.05).Conclusion After treatment with low molecular weight heparin calcium, the healing process of vertebral body after vertebroplasty, to a certain extent, it can increase the bone mass and prevent bone destruction, increase bone strength, and further achieve the treatment of osteoporosis and prevention of osteoporotic fracture in elderly patients with osteoporotic vertebral compression fractures.

low molecular weight heparin calciumvertebroplastycombineosteoporosisfracturecurative effect

贾林、黄德清

展开 >

天津市第三中心医院分院 骨科,天津 300250

低分子肝素钙 椎体成形术 联合 骨质疏松 骨折 疗效

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(2)
  • 9
  • 5